Analysis
Earnings Preview: Improved industry macros to help Canadian Solar in Q4
The solar industry has been affected across the board last year due to tariff wars between the US and China,…
What is NASH and which biotech firms are vying for the first-mover status
NASH, or Nonalcoholic steatohepatitis, is undeniably a golden goose in the pharma space. The biggest corporate attraction towards this liver…
Earnings preview: Buyouts could drive Conagra Brands Q3 results
Conagra Brands (CAG) is scheduled to report its third-quarter results on Thursday before the market opens. The packaged food company’s…
Earnings preview: Tiffany could take a beating from holiday slump, high costs in Q4
Tiffany & Co. (TIF), a leading manufacturer and retailer of designer jewelry, is scheduled to report the fourth-quarter 2018 results…
Earnings preview: Herman Miller to benefit from growing demand in Q3
The market is quite upbeat about the third-quarter financial performance of Herman Miller (MLHR), which is slated to announce the…
Earnings Preview: Strong subscriber growth to boost Zuora’s Q4 earnings
After the IPO in April 2018, shares of the subscription services provider Zuora (NYSE: ZUO) has been volatile touching a…
Earnings preview: Comps to drive Guess? Q4 results
Lifestyle products designer Guess? Inc. (GES) is scheduled to report its earnings for the fourth quarter on Wednesday after the…
Earnings Preview: Aurinia’s Q4 results pivot on AURORA trial updates
Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH/TSX: AUP) rose 13% on February 25 when the US patent office extended the patent…
Earnings preview Q4: Amyris likely to benefit from the new cannabinoid deal
Renewables product company Amyris (AMRS) is set to report its fourth quarter and full-year 2018 results on Monday, March 18…
Tilray (TLRY) Q4 earnings preview: All you need to know
Tilray (TLRY), which has been trailing other cannabis stocks since the start of this year, will be put under the…